𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: Double-blind and open-label studies

✍ Scribed by Roger Messin; Fabienne Carreer-Bruhwyler; Claude Dubois; Jean-Pierre Famaey; Joseph Géczy


Publisher
Springer Healthcare Communications
Year
2006
Tongue
English
Weight
336 KB
Volume
23
Category
Article
ISSN
0741-238X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy and safety of the 200–300 mg su
✍ B. Trimarco; D. Radzik; E. Neveux; A. Wajman; P. Attali; W. Mieghem; J. Ponsonna 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 371 KB

The aim of this multicentre randomised double blind study was to compare the efficacy and safety of the 200-300 mg sustained release diltiazem formulation administered once daily (200-300 SR) with standard diltiazem (D) given three or four times daily to patients with stable angina. Patients aged 59

Safety and tolerability of once-daily ve
✍ Roy W. Jones; Antony Bayer; Fraser Inglis; Andrew Barker; Ravinder Phul 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## Objective To assess the safety and tolerability of three different dosing schedules of memantine in patients with moderate to severe Alzheimer's disease (AD). ## Method This 12‐week, randomised, double‐blind study, investigated three dosing schedules of memantine: OD1 (20 mg once

Efficacy and safety of a new combination
✍ L. Guenther; F. Cambazard; P.C.M. Van De Kerkhof; E. Snellman; K. Kragballe; A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr

A randomized, double-blind study compari
✍ Koo; FOR THE OLP302 STUDY GROUP 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun and Neoral, in patients with severe, chronic plaque-type psoriasis. Patients were randomized on a 1:1 basis to 24 weeks of treatment with Neoral (n = 152) or Sandimmun (n = 157). The starting dose